Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kohjin Bio CoTSE:177A -0.12%19 5-Year Yield-on-Cost % is 1.18 as of Aug. 25, 2026, which is 44% above its 10-year median of 0.82. GuruFocus rates TSE:177A with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 150 Biotechnology companies, Kohjin Bio Co ranks worse than 59.33% on this metric.
Kohjin Bio Co's yield on cost for the quarter that ended in Mar. 2026 was 1.18.
The historical rank and industry rank for Kohjin Bio Co's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:177A'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.57 Med: 0.82 Max: 1.18
Current: 1.18
During the past 5 years, Kohjin Bio Co's highest Yield on Cost was 1.18. The lowest was 0.57. And the median was 0.82.
TSE:177A's 5-Year Yield-on-Cost % is ranked worse than 59.33% of 150
companies
in the Biotechnology industry
Industry Median: 1.65
vs TSE:177A: 1.18
Kohjin Bio Co (TSE:177A) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Kohjin Bio Co 5-Year Yield-on-Cost % Related Terms
TSE:177A vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Kohjin Bio Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kohjin Bio Co 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Kohjin Bio Co's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Kohjin Bio Co is calculated as
Kohjin Bio Co (TSE:177A) has a 5-Year Yield-on-Cost % of 1.18 as of Aug. 25, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Kohjin Bio Co and its competitors. This is 44% above median its historical median of 0.82. Over the past decade, Kohjin Bio Co's 5-Year Yield-on-Cost % has ranged from 0.57 to 1.18. According to the industry distribution chart, Kohjin Bio Co ranks #89 out of 150 companies in the Biotechnology industry, placing it in the top 59.3%.
Is Kohjin Bio Co's 5-Year Yield-on-Cost % too high?
Kohjin Bio Co's current 5-Year Yield-on-Cost % of 1.18 is 44% above median its 10-year median of 0.82. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 1.18. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.65. Kohjin Bio Co's value of 1.18 is 28.5% below this industry median. Based on the distribution chart, Kohjin Bio Co ranks #89 out of 150 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Kohjin Bio Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #89 out of 150 companies for 5-Year Yield-on-Cost %. This places Kohjin Bio Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 1.65. Kohjin Bio Co's value of 1.18 is 28.5% below this benchmark. Historically, Kohjin Bio Co's own 5-Year Yield-on-Cost % has ranged from 0.57 to 1.18 over the past decade. While the company's 10-year median is 0.82 vs. the industry median of 1.65, Kohjin Bio Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.65, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kohjin Bio Co's current 5-Year Yield-on-Cost % of 1.18 is 28.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Kohjin Bio Co and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kohjin Bio Co's current 5-Year Yield-on-Cost % is 1.18, which is 44% above median its own 10-year median of 0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current 5-Year Yield-on-Cost % of 1.18. The current 5-Year Yield-on-Cost % is 1.18, which is 44% above median its 10-year median of 0.82 and 28.5% below the Biotechnology industry median of 1.65. Kohjin Bio Co's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current 5-Year Yield-on-Cost % is 1.18 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
19GF Score
Get the complete analysis for TSE:177A
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 
